| |
|
|
|
|
|
|
|||
|
Blood, 1 August 2007, Vol. 110, No. 3, pp. 954-961. Prepublished online as a Blood First Edition Paper on May 4, 2007; DOI 10.1182/blood-2006-08-043786.
IMMUNOBIOLOGY Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of ß cells1 Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; 2 Howard Hughes Medical Institute and Program in Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY; 3 Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and 4 Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA
The pathogenesis of type 1 diabetes (T1D) involves the immune-mediated destruction of insulin-producing ß cells in the pancreatic islets of Langerhans. Genetic analysis of families with a high incidence of T1D and nonobese diabetic (NOD) mice, a prototypical model of the disorder, uncovered multiple susceptibility loci, although most of the underlying immune defects remain to be delineated. Here we report that aged mice doubly deficient in granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) manifest insulitis, destruction of insulin-producing ß cells, and compromised glucose homeostasis. Macrophages from mutant mice produce increased levels of p40 after LPS stimulation, whereas concurrent ablation of interferon-
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||